Immunotherapy

Immune checkpoint inhibitor therapy appeared associated with an increased risk for major adverse cardiovascular events among patients with cancer and a prior history of cardiovascular disease, according to results of a retrospective study.

Jennifer A. Dantzer, MD, MHS, is focused on improving the lives of children with allergy.

The use of immunotherapy among patients with multiple allergies and comorbidities not only is prevalent, but it also is linked to higher satisfaction with health care professionals, according to a survey conducted by Health Union.

A single dose of immunotherapy treatment prevented reductions in FEV1 among patients with cat allergies and mild asthma, according to a study published in The Journal of Allergy and Clinical Immunology.

Researchers at New York University, Weill Cornell Medicine and New York Genome Center have developed and tested a two-step approach that uses whole-exome sequencing to find genes and pathways that predict response to immunotherapy.

The Parker Institute for Cancer Immunotherapy presented $4.5 million in fellowship and scholarship awards to nine graduate and postdoctoral researchers.

Black and Hispanic patients with advanced hepatocellular carcinoma had a lower likelihood than their white counterparts of receiving immunotherapy, which appeared more effective than chemotherapy for the disease, according to study results.

In this video, Thomas Waddington, MD, assistant clinical professor in the department of medicine, division of pulmonary and critical care medicine at City of Hope National Medical Center, highlights what future research into lung cancer should focus on from a pulmonology perspective.

Jedd Wolchok, MD, PhD, FASCO, has been appointed director of Meyer Cancer Center at Weill Cornell Medicine.

Ravi Salgia, MD, PhD, spoke with Healio about findings presented at ASCO Annual Meeting from a FDA pooled analysis of first-line treatment options for patients with PD-L1 advanced non-small cell lung cancer.